Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Tibbetts

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
JAMA Ophthalmology|November 7, 2014
Understanding the adverse effects of ocriplasmin - replyMichael D Tibbetts, Elias Reichel, Andre J Witkin
JAMA Ophthalmology|March 1, 2014
Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinographyMichael D Tibbetts, Elias Reichel, Andre J Witkin
Nature Immunology|April 30, 2003
The death effector domain protein family: regulators of cellular homeostasisMichael D Tibbetts, Lixin Zheng, Michael J Lenardo
Current Opinion in Ophthalmology|March 28, 2012
Stem cell therapy for retinal diseaseMichael D Tibbetts, Michael A Samuel, Tom S Chang, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 17, 2012
Hypertensive retinopathy in a child caused by pheochromocytoma: identification after a failed school vision screeningMichael D Tibbetts, Richard Wise, Brian Forbes, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|January 15, 2013
Successful management of Burkholderia cepacia keratitis after LASIKJagadesh C Reddy, Michael D Tibbetts, Kristin M Hammersmith, et al.
Ophthalmology|December 3, 2014
Identification of torque teno virus in culture-negative endophthalmitis by representational deep DNA sequencingAaron Y Lee, Lakshmi Akileswaran, Michael D Tibbetts, et al.
Structure (London, England : 1993)|December 4, 2004
Crystal structure of a FYVE-type zinc finger domain from the caspase regulator CARP2Michael D Tibbetts, Eric N Shiozaki, Lichuan Gu, et al.
Ophthalmology|January 19, 2010
Treatment of acute retinal necrosisMichael D Tibbetts, Chirag P Shah, Lucy H Young, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JAMA Ophthalmology|November 7, 2014
Understanding the adverse effects of ocriplasmin - replyMichael D Tibbetts, Elias Reichel, Andre J Witkin
JAMA Ophthalmology|March 1, 2014
Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinographyMichael D Tibbetts, Elias Reichel, Andre J Witkin
Nature Immunology|April 30, 2003
The death effector domain protein family: regulators of cellular homeostasisMichael D Tibbetts, Lixin Zheng, Michael J Lenardo
Current Opinion in Ophthalmology|March 28, 2012
Stem cell therapy for retinal diseaseMichael D Tibbetts, Michael A Samuel, Tom S Chang, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 17, 2012
Hypertensive retinopathy in a child caused by pheochromocytoma: identification after a failed school vision screeningMichael D Tibbetts, Richard Wise, Brian Forbes, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|January 15, 2013
Successful management of Burkholderia cepacia keratitis after LASIKJagadesh C Reddy, Michael D Tibbetts, Kristin M Hammersmith, et al.
Ophthalmology|December 3, 2014
Identification of torque teno virus in culture-negative endophthalmitis by representational deep DNA sequencingAaron Y Lee, Lakshmi Akileswaran, Michael D Tibbetts, et al.
Structure (London, England : 1993)|December 4, 2004
Crystal structure of a FYVE-type zinc finger domain from the caspase regulator CARP2Michael D Tibbetts, Eric N Shiozaki, Lichuan Gu, et al.
Ophthalmology|January 19, 2010
Treatment of acute retinal necrosisMichael D Tibbetts, Chirag P Shah, Lucy H Young, et al.
Pageof 1